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ABSTRACT

Painter, Palak M.S., Department of Neuroscience, Cell Biology, and Physiology, Wright
State University, 2012. Quantitative analysis of glycinergic neurons including Ia
inhibitory interneurons in the ventral spinal cord using a BAC-GlyT2-eGFP transgenic
mouse model.

We are interested in understanding the development of reciprocal inhibition, an
important sensory-motor circuit that prevents co-contraction of antagonist muscles during
locomotion. This effect is mediated by a subset of glycinergic neurons termed Ia
inhibitory interneurons (IaINs). Transgenic mouse models are useful in helping to
identify subsets of neurons in developing animals. In this thesis we first wanted to test the
BAC-GlyT2-eGFP mice model by measuring GFP expression overlap in neurons with
glycine in late-stage embryos (E17.5) and early postnatal animals (P0/P1). Our results
suggest more than 98% of glycinergic neurons at these stages also express GFP in GlyT2EGFP transgenic animals. Secondly, we quantitatively measured the number of IaINs at
P0 and P1 using a combination of GFP expression in this transgenic model together with
other immunohistochemical markers of IaINs. We found that IaINs account for 17% of
glycinergic neurons found in lamina VII at this stage.
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I.

INTRODUCTION

The main goals of this thesis are 1) to validate the BAC-GlyT2-eGFP mice model
by carefully measuring the eGFP-Glycine expression in neurons from lamina VII at late
embryonic and early postnatal stages in a quantitative manner and; 2) to identify Ia
inhibitory interneurons (IaINs) and measure them in a quantitative manner at postnatal
stages using the BAC-GlyT2-eGFP transgenic mice model. This study will build a strong
foundation for the future work in our lab.
Our lab is involved in looking into mechanisms that guide the development of
sensory-motor neuronal circuits, in particular the mechanisms involved in the maturation
of the reciprocal inhibition circuit. Reciprocal inhibition (RI) acts to prevent cocontraction of antagonist flexor and extensor muscles to facilitate normal locomotion. A
unique class of glycinergic interneuron, the Ia inhibitory neuron (IaIN), mediates this
inhibition by integrating sensory feedback from the periphery and controlling the motor
neuron (MN) firing during locomotion (Eccles and Lundberg, 1958). IaINs receive
synaptic contacts from Ia afferents bringing signals from muscles in the limb and make
synapses on the efferent MNs that project to limb muscles with antagonistic function at
the same joints. Excitatory synaptic connections between extensor sensory afferents and
extensor efferent MNs cause the extensor muscles to contract; at the same time, the IaIN
interneurons activated by extensor Ia afferents diminishes electrical activity in flexor
efferent MNs and cause
1

flexor muscles to relax (Figure. 1). Increasing knowledge regarding the development of
normal RI circuit function will shed some light on understanding the changes in RI seen
in disease and injury state.
Locomotion is still under development at birth in humans, unlike some other
mammals that quickly acquire motor skills of posture and the ability to walk at the time
of birth. Therefore, one may speculate that the development of sensory motor circuits
occurs postnatally based on experience dependent mechanisms. The assembly of sensory
motor circuits during development is dependent on the close interaction between the
experience-driven processes and programs of genetic predetermination. This makes
motor circuits highly flexible, enabling reading, modifying and activating the motor
output in response to the changing environment throughout life (Ladle et al., 2007). On
the other hand, basic circuits of the sensory motor system seem to be pre-formed in
embryos in many species. Reciprocal inhibition is present in newborn human infants (Mc
Donough et al., 2001). Although humans undergo significant postnatal maturation in
terms of locomotor skills, the presence of basic sensory-motor circuits at birth implies
earlier specification of the basic elements that create these circuits.
RI is mediated by a single class of glycinergic neurons termed IaINs. The RI
pathway includes many complex neuronal connections, but very little is known about the
role and anatomical organization of IaINs in the early developmental stages of this
circuit. It is known, however, that IaINs are glycinergic, and fortunately, we have a
transgenic mouse model available in our lab that specifically labels glycinergic neurons.
This model, generated by Zeilhofer and his team is a bacterial artificial chromosome
(BAC) transgenic mouse,
2
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Figure 1: Reciprocal Inhibition Circuit. The circuit mediating reciprocal inhibition is
composed of Ia afferents (illustrated using red dashed lines) originating from muscle
spindle primary endings and exerting monosynaptic excitatory actions on both synergist
MNs (pink) and IaINs (yellow) which act to inhibit the MNs of antagonist muscle. The
subset of IaINs contacted by flexor-Ia afferents is different than those contacted by
extensor-Ia afferents. Hence, flexor Ia-afferents only evoke inhibition of extensor MNs,
and extensor-Ia afferents only evoke inhibition of flexor MNs. Blue arrows indicate the
direction of information flow in the circuit.
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which specifically expresses enhanced green fluorescent protein (eGFP) under the control
of the promoter of the glycine transporter (GlyT) 2 gene, which is a reliable marker for
glycinergic neurons (Zeilhofer et al., 2005). Past studies have shown that BAC
transgenic models can successfully be used to express specific proteins under the control
of the promoter of a known gene to label cells of interest. (Heintz, 2001). Zeilhofer and
colleagues showed that neurons expressing GlyT2-EGFP were intensely fluorescent, and
their dendrites and axons could be visualized in great detail, but they did not justify their
results in a quantitative manner. They simply commented that “the vast majority of
eGFP-positive cells were strongly immunoreactive for glycine” (Zeilhofer et al., 2005).
Also all the experiments were carried out using adult mice. As one of the focuses of this
study, we wanted to quantify for the first time eGFP-glycine coexpression in the GlyT2eGFP mouse model.
Another focus of our study was identifying inhibitory IaINs from among other
inhibitory neurons in the ventral spinal cord, and focused on mapping and locating IaINs
to further understand the anatomical organization of IaINs in this sensory motor circuit.
Past studies have looked into the location of IaINs in adult animals (Jankowska, 1992),
but we wanted to measure the IaINs located in the lamina VII in a quantitative way using
the GlyT2-eGFP mice model at early postnatal stages which has not been done before.

5

II.

BACKGROUND

Locomotion is fundamental to an animal’s life and is controlled by neuronal
networks in the central nervous system (CNS). Coordinating complex movements
involve multiple elements of the CNS, such as cortex, cerebellum, basal ganglia,
brainstem, and spinal cord. Different motor control features are provided by each
component. Neuronal circuits contained entirely within the spinal cord produce basic
rhythmicity and patterning for stepping and other locomotion behaviors. There is limited
knowledge of how spinal cord circuits develop and how different types of neurons are
generated, specified, and incorporate themselves into these circuits. In order to
understand the maturation of motor control, and potential abnormalities and dysfunctions
that may occur during early development, it is very important to understand how and
when initial connections are made in this pathway, and how and when their maturation
occurs.
Past studies in the cat, by Eccles, Lundberg, Jankowska and others went a long
way toward defining the spinal reflex circuitry in adult animals including the properties
of the constituent interneurons and their actions on MNs. Most studies examining the
neural circuits involved in quadripedal locomotion have been undertaken in adult cats and
rodents (Eccles JC, 1968; Lundburg A, 1979; Jankowska E, 2001; Jankowska E. &
Edgley S., 1993). Experiments in the cat, in particular, have helped in understanding
pathways of spinal reflexes in terms of their organization and how sensory feedback is
6

involved in shaping movements. Sensory feedback is essential for starting and
maintaining the correct locomotor rhythm. Recordings from the cat spinal cord have
identified and characterized some of the interneuron cell types that are interposed in these
spinal sensorimotor pathways. (Eccles JC, 1968, Lundburg A, 1979, Jankowska E, 2001,
Jankowska E. & Edgley S., 1993). The analysis of motor behaviors has long been at the
center of efforts to understand how the nervous system is organized and functions, with
Sherrington’s studies providing important first insights into the integrative nature of
neural pathways, the reflex arc, and the control of reciprocal motor actions by central
inhibitory pathways (Sherrington, 1906).
This thesis revolved around identifying inhibitory IaINs from other neurons, and
also focused on mapping and locating IaINs to set the stage for further experiments to
understand the functionality of IaINs in sensory motor circuits. Inhibitory networks like
recurrent and reciprocal inhibition control the activity of adult motoneurons (PierrotDeseilligny & Burke, 2005). Recurrent inhibition is a process of inhibition of motor
neurons by particular interneurons termed Renshaw cells (RCs) that receive excitatory
inputs from motor axons (Eccles et al., 1954). This is in contrast to reciprocal inhibition
whereby inhibition of antagonist motor pools is evoked by stimulation of proprioceptive
afferents (Eccles et al., 1956). Renshaw cells and IaINs have different functional roles
and connections in an adult but they are both located in lamina VII (Jankowska, 1992) in
the ventral horn of the spinal cord.

7

A.

Reciprocal Inhibition (RI) in adults:
The demonstration that the contraction of a muscle is accompanied by the

relaxation of its antagonist was shown by Sherrington in 1897 who named this effect
“reciprocal inhibition”. The possibility that reciprocal inhibition was mediated by Ia
afferents directly affecting MNs was postulated by Lloyd (1941). However, more than a
decade later, Eccles demonstrated in 1956 that an interneuron (IN) was interpolated in the
reciprocal inhibitory pathway. This interneuron was first called the “Ia intermediate
interneuron”, which evolved into its current name, “Ia inhibitory interneurons (IaIN)”
The reciprocal inhibitory circuit as we know it today involves Ia afferents originating in
the muscle spindle primary endings that exert monosynaptic excitatory action onto IaINs
that act to inhibit motor neurons of the antagonistic muscle (Eccles and Lundberg, 1958).

B.

Early Development of Reciprocal Inhibition:
Appropriate Ia afferent connections must be made with specific IaINs and those

IaINs must make further contacts with their targeted MNs for the normal development of
RI circuits. For example, Quadriceps (Quad) Ia afferents make connections with specific
IaINs during development, such that when stimulated by Quad Ia afferents, these IaINs
inhibit the MNs projecting to hamstrings muscles which act as antagonists to Quad at the
knee joint. How and when these connections made at embryonic stages is still unknown.
One can assume that initially IaINs may be contacted by Ia afferents from many,
including inappropriate, muscle sources. During development, reinforcement of Ia-IaINs
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connections that lead to appropriate inhibition might take place as the animal ages,
whereas any inappropriate connections may be weakened or disappear.
C.

Role of IaINs in adults:
The sensory-motor circuit that mediates RI acts to prevent the co-contraction of

antagonist flexor and extensor muscles (Figure 1). IaINs receive inputs from Ia
proprioceptive afferents and generate reciprocal inhibition by inhibiting motoneurons in
motor pools innervating muscles that are antagonists of the muscle of origin of the Ia
afferent (Eccles et al., 1956). Earlier studies have shown that IaINs are found in lamina
VII of the ventral horn of the spinal cord. Subpopulations of interneurons with opposite
actions, those mediating Ia reciprocal inhibition from flexors to extensors and from
extensors to flexors of a given joint, have been found to inhibit each other (Hultborn et
al., 1976) and their activity can be controlled by Renshaw cells (Hultborn et al., 1971).

D.

Early development of IaIN:
Interneurons (INs) and MNs are the two general classes of neurons in the spinal

cord. MNs generate the motor output to the muscle, while INs establish local circuits that
control the activity of MNs. Initial developmental studies focused on MN development
(Jessell, 2000). Recently, interest has turned to spinal cord INs. Previous studies have
shown that IaINs, which mediate reciprocal inhibition, derive from V1 interneurons
(Alvarez et al., 2005). The finding that all adult spinal INs develop from a few
embryonic subclasses; six dorsal (dl1, dl2, dl3, dl4, dl5, and dl6) and four ventral (V0,
V1, V2, and V3) was a major breakthrough (Goulding, 2009). Each of these interneuron
9

classes are derived from distinct progenitor domains located in different regions of the
proliferative neuroepithelium in the early neural tube. The expression of the engrailed-1
(En-1) transcription factor was found to be a key marker for V1 interneurons (Sapier et
al., 2004). Past studies undertaken using adult mice, has shown that out of the total V1
interneuronal population, 10% of interneurons were counted as RCs and 13% were
counted as IaINs (Alvarez, 2005).

E.

Location, anatomy and morphological identification:
IaIN’s position in the ventral horn was first determined from electrophysiological

recordings (Hultborn et al., 1971) and they also showed that IaINs are directly inhibited
by RCs located in the same spinal segment as the IaIN (Hultborn et al., 1971). More
specific information on exact location came from intracellular labeling of IaINs. They
were found in lamina VII (LVII) dorsal or medial to lamina IX (Burke et al., 1971,
Jankowska 1992). IaINs are always located in the same spinal cord segment as the Ia
afferents that excite them. Therefore, to exert reciprocal inhibition between pools of
motoneurons located segments away, the axons of IaINs need to ascend or descend in the
white matter surrounding the ventral horn and then send collaterals to target motor pools
either locally or several segments away (Jankowska and Lindstrom, 1972). In our study,
we identified IaINs by looking for eGFP positive neurons that received Ia afferent inputs,
as well as inputs from RCs using a BAC-GlyT2-eGFP transgenic mice model.
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F.

GlyT2-GFP Transgenic Mice Model:
Biomedical research to study developmental biology has been enhanced by using

transgenic mice as animal models. Bacterial Artificial Chromosome (BAC) DNA vectors
have been developed to hold much larger pieces of DNA that serves as the promoter
regions for specific genes than normal plasmid vectors. BAC transgenic mice models
can be generated by microinjecting purified BAC DNA into the nucleus of fertilized
mouse eggs.
To shed some light on the morphological and functional characteristics of
glycinergic neurons, Zeilhofer and his team generated BAC transgenic mice. The BAC
clone 365E4 (179,508 base pairs long) used by Zeilhofer and his team, contained the
entire glycine transporter 2 (GlyT2) gene and an additional 105 kb DNA flanking the 5’
end of exon 1 and 21 kb DNA flanking the 3’ end of the last exon. The facilitation of
eGFP expression was carried out by removal of exon 2 at the beginning of GlyT2 gene
using a two-step homologous recombination procedure and inserting eGFP cDNA in the
place of exon 2. Several homologous recombination and restriction digest steps were
carried out to remove unwanted vector sequences and to achieve the final result: a
transgenic mouse line which expressed enhanced GFP (eGFP) under the control of the
promoter of the glycine transporter gene 2 (GlyT2).
For our experiments, an active breeding colony of BAC-GlyT2-eGFP mice had
been established in our animal facility at Wright State University with Dr. Zeilhofer’s
permission. Thus in the present study, we will demonstrate the eGFP-Glycine percentage
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overlay in a quantitative way using BAC-GlyT2-eGFP transgenic mice model at
embryonic day E17.5, and postnatal day P0 and P1. We will then locate and measure in a
quantitative manner the percentage of IaINs in comparison to the other glycinergic
neurons using BAC-GlyT2-eGFP mice model at postnatal day P0 & P1.
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III.

SPECIFIC AIMS

Aim 1: To test and validate in a quantitative manner the GlyT2-eGFP transgenic mice
model at late embryonic and early postnatal stages. GlyT2-GFP is a transgenic mouse
line in which green fluorescence protein (GFP) is expressed under control of the GlyT2
(neuronal glycine transporter) promoter (Zeilhofer et al., 2005). Previous studies have
demonstrated expression of GFP in this mouse model in glycinergic neurons in the brain
and spinal cord of an adult mouse, but did not quantify whether GFP was expressed in all
glycinergic neurons. We are looking to quantify the percent eGFP-Glycine co-expression
overlap by manually identifying GFP positive cells and then measuring the intensity
glycine expression from confocal image stacks using Image-Pro software. Several
sections from a single animal were averaged and then total average values (±SEM) from
E17.5 (n=4) and P0/1 (n=5) were plotted in graphs to show the percent GFP-Glycine
overlap.
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Aim 2: To identify and measure in a quantitative manner immunohistochemically
defined IaINs in the ventral horn of the spinal cord in GlyT2-eGFP postnatal mice. IaINs
are glycinergic neurons that mediate reciprocal inhibition and previous studies have
shown that these neurons are located in lamina VII of the ventral spinal cord. We
quantified the abundance of IaINs in comparison to the total number of GlyT2-eGFP
positive cells found in the lamina VII of postnatal spinal cord. Several sections from a
single animal were scanned with confocal imaging and analyzed for IaINs and the total
average values (±SEM) from 4 animals at P0/1 were determined.
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IV.

A.

MATERIALS & METHODS

Animals used for the experiments:
All animal procedures were performed according to National Institutes of Health

guidelines and were reviewed by the local Laboratory Animal Use Committees at Wright
State University. For our experiments, an active breeding colony of BAC-GlyT2-eGFP
mice had been established in our animal facility at Wright State University with Dr.
Zeilhofer’s permission.
Time-pregnant females for GlyT2-eGFP transgenic mice model were created by
mating GlyT2-eGFP positive males with C57/BL6 wild-type females. Once mated,
regular vaginal plug checks were carried out every morning to record the time of the
pregnancy. Once plugged, the females were separated into different cages and the time
and date of the plug was recorded. The plugged females were then observed till
embryonic day 17.5 and then euthanized to isolate the embryos. The embryos were
genotyped using a fluorescent dissecting microscope to visualize the strong GFP signal
through the skin of the embryo. Positive embryos were then further used for
immunohistochemical experiments.
For P0/P1 pups, GlyT2-eGFP males were mated with C57/BL6 wild-type females
as described for matings to generate embryos. On the day of birth, the litter was
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genotyped using a fluorescent dissecting microscope to visualize the strong GFP signal
through the skin of the pup. Positive pups were used for further immunohistochemical or
retrograde labeling experiments.

B.

Tissue Preparation for analysis:

EGFP-Glycine overlay (E17.5):
Time pregnant females were euthanized with Euthasol (pentobarbital) at E17.5 and
embryos removed and transferred into an oxygenated ACSF solution. A ventral
laminectomy was carried out on GFP positive embryos to expose the spinal cord and the
spinal cord was submerged in tubes of paraformaldehyde for 2 hours (post fixed).
Afterwards the spinal cord was washed with PBS (either 2-4 hours or overnight) and was
then transferred into tubes of 30% sucrose solution (either 2-4 hours or overnight). A
portion of the L4-L6 region of the spinal cord was cut and frozen onto a cutting block via
Tissue Freezing Medium (OCT, Tissue Tek). The frozen tissue blocks were then cut into
12 micrometer sections using a cryostat and mounted directly on a slide for further
immunohistochemistry.

EGFP-Glycine overlay (P0/P1):
Neonatal P0/P1pups were anesthetized via exposure to ice cold water for
approximately 2 minutes then transcardially perfused with 5ml of ice-cold
paraformaldehyde (PFA). Pups were then eviscerated and decapitated. A ventral
laminectomy was carried out and the spinal cord was isolated into tubes of
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paraformaldehyde for 2 hours (post fixed). Afterwards the spinal cord was washed with
PBS (either 2-4 hours or overnight) and was then transferred into tubes of 30% sucrose
solution (either 2-4 hours or overnight). A portion of the L4-L6 region of the spinal cord
was cut and frozen onto a cutting block via Tissue Freezing Medium. The frozen tissue
blocks were then cut into transverse 12μm sections using the cryostat and mounted
directly on a slide for further immunohistochemistry.

Retrograde labeling of primary afferents:
Retrograde labeling of primary afferents can be achieved by dorsal root fill
technique. This strategy labels all types of afferents, but different types of afferents have
different termination zones. Ia afferents extend their axons and make contacts with IaINs
in lamina VII and MNs in lamina IX (Brown & Fyffe, 1978). Ib afferents, another
proprioceptive afferent type, extends its axons and terminates in more dorsal lamina of
the spinal cord (Brown & Fyffe, 1978). Group II muscle spindle secondary afferents,
even though they terminate in the same lamina as Ia afferents, are not known to make
contacts with IaINs (Jankowska, 1992). Thus, primary afferent terminals making contacts
with IaINs can be identified by their unique termination zone following retrograde
labeling through dorsal root-fill experiments.
The neonatal mice P0/P1 [n=4] GlyT2-eGFP transgenic mice utilized in this study
were anesthetized via exposure to ice-cold water for approximately 2 minutes. The mice
were then transcardially perfused with 5ml of ice-cold oxygenated artificial cerebrospinal
fluid (ACSF; containing in mM: 127 NaCl, 1.9 KCl, 1.2 KH2PO4, 1 MgSO4•7H2O, 26
17

NaHCO3, 16.9 D(+)-Glucose monohydrate, and 2 CaCl2). Mice were decapitated and
eviscerated. The vertebral column, including the spinal cord, was then transferred into a
recirculating bath of ice-cold oxygenated ACSF. This was followed by a dorsal
laminectomy of the spinal column and careful removal of the dura from the spinal cord.
All the ventral roots on both the sides of the spinal cord as well as all the dorsal roots of
lumbar segment were cut, except dorsal root L4 was kept intact on the side of interest.
The hemisected spinal cord was then pinned down in a sylgard covered dish filled with
recirculating oxygenated ACSF at room temperature while setting up the pipettes filled
with Rhodamine dextran to label the primary afferents in dorsal root L4. The dye
transportation takes place via active metabolic processes and requires overnight
incubation (<18 hours). The next morning the spinal cord was isolated into a tube of
paraformaldehyde for 2 hours (post fixed). Afterwards the spinal cord was washed with
PBS (either 2-4 hours or overnight) and was then transferred into tubes of 30% sucrose
solution (either 2-4 hours or overnight). A portion of L4-L6 segment of the spinal cord
was then cut and frozen into a cutting block via Tissue Freezing Medium. The frozen
tissue blocks were then cut into transverse 20μm sections using a cryostat and mounted
directly on a slide for further immunohistochemistry.

18
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Figure 2: Illustration of retrograde labeling of primary afferents via lumbar 4
dorsal root (DR4). Sensory axons in the dorsal root (red) are labeled via a rhodamine
dextran filled micropipette. Sensory axon projections can be visualized in ventral spinal
cord, including lamina VII and lamina IX. We focused our analysis on eGFP positive
glycinergic neurons (green pentagons and squares) are located in lamina VII, surrounding
lamina IX in the ventral horn of the spinal cord. This technique allows labeling of all
primary afferent classes projecting in DR4. The green square shaped cells labeled with
eGFP illustrate the location of IaINs that are found in lamina VII, medial or dorsal to
lamina IX.
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C.

Immunohistochemistry:

EGFP-Glycine overlay:
Slides of fixed E17.5 and P0/P1 tissue were taken through a step-by-step process
of one PBS ( 0.1 M Phosphate Buffer Saline) wash for five minutes followed by
immersion in a citrate buffer solution, which works as an antigen retrieval agent to
enhance the glycine signal, for 20 mins at 95°C. Slides were then washed again in PBS.
Next, the slides were incubated in Normal Donkey Serum (NDS) solution for an hour
(Blocking Buffer (1X PBS + 1% Bovine Serum Albumin (BSA) + 10% Triton) + 1:100
NDS) to block the background. Primary antibodies (rat α glycine (Gly), 1:800 and mouse
α Neuronal Nuclei (Neu N), 1:1000) were then added onto the slides and left on
overnight at 4ºC. The slides were then washed twice with PBS (5 mins each) before
adding the secondary antibodies (Cy3 donkey α rat, 1:1000 and Cy5 donkey α mouse, 1:
1000) for 2-4 hours at room temperature. The slides were then taken through three PBS
washes (5 mins each) before being cover slipped using Vectashield mouting medium
(Vector Laboratories).

Retrograde labeling experiments:
Slides with fixed P0/P1 tissue were first washed one time with PBS for five
minutes. Next, the slides were incubated in NDS solution for an hour to reduce
background signal. Primary antibodies (guinea pig α rhodamine (RHOD), 1:5000 and
rabbit α calbindin (CB), 1:1000) were then added on to the slides and left on overnight at
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4ºC. The slides were then washed with PBS twice (5 mins each) before adding the
secondary antibodies (Cy3 donkey α guinea pig, 1:100 and Cy5 donkey α rabbit, 1: 1000)
for 2-4 hours at room temperature. The slides were then taken through three PBS washes
(5 mins each) before being cover slipped using Vectashield mouting medium.

Imaging:
The slides were imaged and analyzed using an Olympus FV1000 confocal microscope.
Fluorophores were excited with line lasers of 405nm, 488nm, 568nm, and 633nm.

Analysis:
Images were composed using Fluoview (FV) software, Image Pro Plus 5.1, and
CorelDraw 14. Brightness, contrast and sharpness in the images were enhanced without
altering any content within the images.

22

Table 1: Antibodies used for immunohistochemistry
Antibody

Dilution Host

Manufacturer

Lot#

Green Fluorescence
Protein (GFP)

1:5000

Sheep

ABD Serotec

4745-1051

Glycine (GLY)

1:800

Rat

Immuno solution

161002

Calbindin (CB)

1:1000

Rabbit

Swant

CB38a, 9.03

Neuronal Nuclei (Neu. N) 1:1000

Mouse

Millipore

LV1825845

Vesicular Glutamate
1:10,000
Transporter 1 (VGLUT1)

Guinea Pig

Chemicon

LV1567574

Glycine Transporter 2
(GlyT2)

1:2000

Guinea Pig

Millipore

NG1809675

anti sheep DyLight 488

1:1000

Donkey

97222

anti rat CY3

1:1000

Donkey

anti guinea pig CY3

1:1000

Donkey

anti guinea pig CY5

1:1000

Donkey

Jackson Immuno
Lab
Jackson Immuno
Lab
Jackson Immuno
Lab
Jackson Immuno
Lab

anti mouse DyLight 649

1:1000

Donkey

97084

anti rabbit Alexa 647

1:100

Donkey

Jackson Immuno
Lab
Jackson Immuno
Lab

Rhodamine (RHOD)

1:100

Guniea Pig

Invitrogen

N/A
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100582
96577
J706-175148

99912

V. RESULTS
Aim 1: To test and validate in a quantitative manner the GlyT2-eGFP transgenic mice
model at late embryonic and early postnatal stages.
The work in our laboratory is looking to better understand the early development
of the sensory motor circuit that mediates reciprocal inhibition. Reciprocal inhibition is
achieved via a class of glycinergic interneurons that receive Ia afferent input and act to
inhibit motor neuron targets. One tool that can be used to assist in identifying these
specific interneurons is a transgenic mouse model wherein glycinergic neurons express
GFP (Zeilhofer, 2005). To lay the foundation for future experiments, we needed first to
validate expression of GFP in this mouse model in a quantitative manner.
BAC transgenic mice models can be generated to express a specific reported
protein under the control of a promoter of a known gene in order to identify the cells of
interest (Heintz, 2001). This technique was applied by Zeilhofer and colleagues to label
glycinergic neurons, based on expression of GlyT2 in subsets of neurons (Zeilhofer et al.,
2005). A statement that “the vast majority of eGFP-positive cells were strongly
immunoreactive for glycine” was made by Zeilhofer and his team in 2005 (Zeilhofer et
al., 2005). Yet, so far no one has carefully tried to measure the eGFP expression overlap
with glycine immunoreactivity in a quantitative manner. In addition, no analysis of the
model at earlier stages, including in embryos, has been performed. Therefore, our first
aim was to test and validate the BAC-GlyT2-eGFP mouse model at early developmental
stages in a quantitative manner.
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A subset of neurons in the spinal cord use glycine as a neurotransmitter. Glycine
is also a fundamental amino acid and must be packaged into synaptic vesicles for release
as a neurotransmitter. The protein in neurons that is responsible for this is glycine
transporter type 2 (GlyT2). The promoter of the GlyT2 gene was used to construct a
BAC used in the transgenic animal model we are studying. We used immunoreactivity
for GlyT2 and glycine as key markers to carefully quantify the percentage overlap with
GFP expression in GlyT2-EGFP animals. We collected lumbar spinal cord tissue from
GlyT2-eGFP positive animals at embryonic day 17.5 (E17.5; n=4) and postnatal day 0
and 1 (P0/P1; (n=5). Previous studies have shown that sensory-motor connectivity begins
at E17.5 and one of the focuses of our study in future would be to understand the function
of RI at birth, hence the reason we chose these two time points for our current study.
Genotyping of embryos was facilitated by strong GFP fluorescence signal in the spinal
cord that was visible through the skin using an epifluorescence dissecting microscope.
Genotyping was confirmed by post hoc PCR.
First, we determined if the native eGFP signal in GlyT2-eGFP animals was strong
enough after fixation to allow for analysis, or whether signal enhancement with
antibodies against GFP was required to detect weakly labeled cell structures. We
performed this analysis using both 50µm floating sections as well as 12µm tissue sections
fixed to slides. Selected GFP+ cells were visualized by confocal laser scanning
microscopy with or without antibody staining against GFP in different tissue sections.
We found even the finest neuronal processes could be seen without antibody staining, and
that sections stained with the antibody showed poor penetration. This experiment
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revealed that anti-eGFP antibodies did not penetrate more than 6-8µm from the surface
using either 50µm floating sections or 12µm tissue sections fixed to slides. In addition,
anti-GFP staining did not label more neuronal structures than seen with native eGFP
fluorescence after fixation (data now shown). Therefore, all following experiments were
performed without further amplifying the eGFP fluorescence (see Figures 3A, 4A for
examples).
Initially we attempted to validate the faithfulness of GFP expression in GlyT2eGFP mice using an antibody against the membrane-bound glycine transporter 2 (GlyT2).
Previous studies have shown that immunoreactivity (IR) for GlyT2 is a reliable marker
for glycinergic neurons in the CNS (Poyatos et al., 1997; Liu et al., 1993). Only axon
terminals are labeled by GlyT2 antibodies (Spike et al., 1997) as this transporter is
concentrated at axon terminals in order to load synaptic vesicles with glycine. In our
hands, although the GlyT2 antibody was able to label the axon terminals in adults, GlyT2
IR was not distinct in E17.5 embryos and P0-P1 pups (data not shown). The GlyT2 signal
in the axon terminals of E17.5, P0 and P1 tissue sections was very weak compared to the
background, which made it impossible to accurately measure the GlyT2-eGFP expressing
cells in a quantitative manner.
To show the general positioning of all neurons in spinal cord, we used the panneuronal marker NeuN (Figure 3C, 4C). This allowed us to identify the pools of large
motor neurons in lamina IX of the ventral horn. Visualizing the border of lamina IX was
important for our study as we were focusing on studying the glycinergic neurons in the
lamina VII right adjacent to the lamina IX (Figure 3A, C; Figure 4A). Even after the
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Figure 3: Representative section illustrating glycine in a transgenic GlyT2-eGFP
mouse at E17.5 A) Transverse section of L4 ventral horn showing eGFP expression in a
GlyT2-eGFP embryo. B) Immunoreactivity for glycine on the same section. C)
Immunoreactivity for NeuN on the same section. A pool of large neurons (motor
neurons) is clearly seen to be labled with pan-Neu N in lamina IX. D) Overlay of A and
B showing co-localization of eGFP (green)-glycine (red) in neuron somata. E) Merged
view of A, B and C showing eGFP-glycine overlay in yellow and NeuN labeled cell
bodies in blue.
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Figure 4: Representative section illustrating glycine in a transgenic GlyT2-eGFP
mouse at P0/P1. A) Transverse section of L4 ventral horn showing eGFP expression in a
GlyT2-eGFP mouse at P0/P1. B) Immunoreactivity for glycine on the same section. C)
Immunoreactivity for NeuN on the same section. A pool of large neurons (motor
neurons) is clearly seen to be labled with pan-Neu N in lamina IX. D) Overlay of A and
B showing co-localization of eGFP (green)-glycine (red) in neuron somata. E) Merged
view of A, B and C showing eGFP-glycine overlay in yellow and NeuN labeled cell
bodies in blue.

30

paraformaldehyde fixation, strong eGFP fluorescence was observed in both embryonic
and postnatal spinal cords tissue sections (Figure 3 A, F & 4 A, F) and hence further
amplification of the signal was not needed. The eGFP fluorescence was readily seen in
subsets of neurons throughout the spinal cord with the exception in lamina IX, where MN
cell bodies are located.
Visual inspection of the staining patterns of glycine and NeuN using the GlyT2eGFP mice model at embryonic and postnatal stages, revealed that at E17.5 neurons were
found to be generally more densely packed in the ventral horn of spinal cord (Figure 3A,
C) in comparison to the more evenly distributed band of eGFP-Glycine expressing
neurons seen adjacent to lamina IX at P0 and P1 (Figure 4A, C). By eye one can easily
see a degree of overlap between the eGFP and glycine (Figures 3&4) but further analysis
was carried out to quantify the eGFP-Glycine overaly.
From figure 3 and 4, we can say that there was a good degree of overlay between
eGFP and glycine expression; however after taking a closer look by looking at the images
taken at higher magnification using confocal microscopy, we observed that there were a
few cells which strongly expressed eGFP but had either weak or no expression of glycine
(Figure 5). Similarly, it was also observed that there were couple cells in each section
which displayed strong glycine signal, but very weak EGFP signal. The fact that we
noticed some cells were weakly expressing eGFP but strongly expressed glycine or vice
versa when visualized by confocal laser scanning microscopy, did not imply that the
eGFP or glycine expression was completely absent in them, the reason being that the
expression might still be there but may have overwhelmed by the strong expression of
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one or the other channel and therefore not visible at a glance. Hence to measure the
degree GFP-Glycine overlap we used a software called Image Pro, which allowed us to
manually map out the eGFP positive cells in the lamina VII by drawing a trace around the
cell and then objectively measure the intensities for eGFP and glycine (Figure 6).
Image-Pro software measures the highest pixel intensity of multiple channels of
the traced cell derived from a three dimensional image. After identifying GFP positive
cells and drawing regions of interest around the cells using one of the drawing tools in an
Image Pro, we limited the intensity measurement to those particular regions. Background
intensities were then measured by separately drawing regions of interest in the neuropil to
decide on the cut-off point for both eGFP and glycine channels for every single image
analyzed Intensities of as many GFP positive cells as could be found in lamina VII in
each image were manually traced and measured. In addition, five background intensities
for EGFP–Glycine overlay were measured by tracing the background signal for every
single image. The average of background intensities of eGFP and glycine were then
calculated separately and a 10% cut off point intensity was selected, i.e. a cell expressing
10% higher signal than the background cut off point was counted as a positive cell and
cells with fluorescent intensity within or below the 10% background cut off point were
discarded from the final result count for each channel. The rationale for selecting a 10%
cut off point for both the channels was due to the higher background signal for glycine in
comparison to the actual glycine positive cells. It was noticed that by raising the cutoff
point to more than 10%, we were discarding some actual glycine positive cells labeled in
the lamina VII of the spinal cord. Figure 6 is an example of this analysis showing five
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Figure 5: Demonstration of immunoreactivity of an antibody against glycine in a
transgenic GlyT2-eGFP mouse spinal cord. A) View of a transverse section of L4
ventral horn showing eGFP expression (green) in a GlyT2-eGFP mouse. The arrow
labeled in yellow points at a cell which is eGFP positive but was found to be negative for
glycine IR. The blue arrows are pointed towards the cells which are IR for glycine, but
lacked in expressing eGFP. The white arrows represent eGFP positive neurons which are
also IR for glycine. B) Transverse section of L4 ventral immunostained with an antibody
against glycine (red) in a GlyT2-eGFP mouse. C) Overlay of A and B showing colocalization of eGFP (green)-Glycine (red) in neuron somata and dendrites. The white
arrows represent the eGFP positive neurons which are also IR for glycine.
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Figure 6: Representation of eGFP-Glycine overlay analysis in a GlyT2-eGFP mouse.
A) Regions of interest (numbered 1-5) drawn around strong eGFP expressing cells
(green). Letter B represents similar sized regions which were manually mapped to
measure GFP and glycine signal intensity in background to decide the cutoff point. B)
View of eGFP-Glycine expressing neurons showing almost perfect overlap. The cells 1, 2
and 3 were eGFP expressing cells which were also strongly IR for glycine. Cells 4 and 5
were observed to be eGFP positive but were weakly labeled with glycine.

36

eGFP positive cells mapped manually (figure 6A) using a drawing tool to measure the
eGFP and Glycine intensities and three background regions mapped to work out the 10%
cut off point. After the analysis, cells 1, 2 and 3 were counted as eGFP-Glycine positive
cells (figure 6B). Due to glycine intensity below the cutoff point, cells 4 and 5 (figure
6B) were counted as glycine negative cells.
Data from a total of four animals for E17.5 and a total of five animals for P0/P1
were collected and are displayed in Tables 2 and 3. Several sections from each animal
were analyzed and averaged. Then the total average values (±SEM) from E17.5 (n=4)
and P0/1 (n=5) were plotted into graphs (Figures 7 and 8). These results showed that at
E17.5, 90.7% eGFP positive cells were also positive for glycine and 98.1% of glycine
positive cells were eGFP positive (Figure 7). At P0/P1, 90.3% of eGFP positive cells
were glycine positive and 98.9% glycine positive cells were also eGFP positive (Figure
8).
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Figure 7: Graphical representation of the percent eGFP-Glycine overlay at E17.5 in
the lamina VII of a GlyT2-eGFP mouse model. The green bar shows the percentage of
eGFP expressing cells which were also found to be positive for glycine. The percent
GFP-Glycine overlap was analyzed manually, by identifying GFP positive cells and then
measuring the intensity of the glycine channel using Image-Pro software. Several
sections from a single animal were averaged and then average values (±SEM) from E17.5
(n=4)is plotted in this graph. The red bar represents the percentage of all the glycine
positive cells which were observed to be strongly labeled with GFP.
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Figure 8: Graphical representation of the percent eGFP-Glycine overlay at P0/P1 in
the lamina VII of a GlyT2-eGFP mouse model. The percent GFP-Glycine overlap was
analyzed manually, by identifying GFP positive cells and then measuring the intensity of
the glycine channel using Image-Pro software. Several sections from a single animal
were averaged and then average values (±SEM) from P0/1 (n=5) is plotted in this graph.
The green bar represents the percentage of all GFP positive cells which were observed to
be strongly labeled with glycine. The red bar represents the percentage of all the glycine
positive cells which were observed to be strongly labeled with GFP.
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These results confirmed that the BAC-transgenic mice model expresses intense
and stable green fluorescent protein (eGFP) under the control of the GlyT2 promoter,
specifically in glycinergic neurons and can help to identify numerous eGFP-expressing
neurons throughout the spinal cord at as early as E17.5 time point. Further it was
observed that the EGFP-Glycine expression and distribution was consistent at both the
time points making this model reliable for use in future experiments.
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Aim 2: To identify and measure in a quantitative manner, immunohistochemically
defined IaINs in the ventral horn of the spinal cord of early postnatal mice.
In this study, Ia inhibitory interneurons (IaINs) were identified using
immunohistochemical markers. Having validated the GlyT2-eGFP mouse model as
faithfully expressing GFP in glycinergic neurons, we were able to use this model in our
analysis of IaINs. Our criteria for identification of IaINs included: eGFP expression in
neurons receiving synaptic contacts from CB-IR Renshaw cell axons as well as from Ia
afferents. The relative abundance of IaINs among all glycinergic neurons located in the
ventral horn is unknown, and estimating the number of IaINs among all GlyT2-eGFP
neurons will set the stage for future studies investigating the properties of these neurons.
Because these future functional studies will focus on properties of IaINs in postnatal
animals, we made our analysis of IaINs in lumbar spinal cords from P0/P1 mice.
Numbers of IaINs were quantified by manual analysis of confocal image stacks.
An important identifier an IaIN is that these interneurons are contacted by Ia
primary afferents. After testing several anatomical methods to label primary afferents in
postnatal mice, we used retrograde tracing with Rhodamine-conjugated (RHOD) dextran
from the lumbar 4 dorsal root to label primary afferents in early postnatal spinal cords.
Several attempts were made and the four experiments that showed the greatest degree of
primary afferent labeling were selected to carry out further analysis. In order to enhance
the signal in primary afferents after fixation following retrograde transport, the RHOD
signal was further amplified using an antibody against RHOD. Initially, we wanted to
combine labeling of primary afferent axons with a specific presynaptic marker indicating
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the presence of a synapse. For this purpose, we attempted to use an antibody against
vesicular glutamate transporter isoform 1 (VGLUT1). VGLUT1-IR has been proved to be
a specific marker of sensory afferent terminals in postnatal and developing mice in
previous studies. Interestingly, VGLUT1-IR in our study was found to be noticeably
weaker at P0/P1 than at later postnatal stages (data not shown), probably because the
protein has not been sufficiently enriched in synaptic terminals at that stage.
Consequently, we labeled primary afferent terminals only with RHOD dextran.
As mentioned before, a classic property of IaINs is direct inhibition from RCs
(Hultborn et al., 1971; Todd et al., 2003; Alvarez et al., 2004) Anatomical studies have
found that some INs in the ventral horn receive a dense innervation on the cell body and
proximal dendrites from Renshaw cells (labeled with calbindin antibodies). In parallel
with electrophysiological criteria (Alvarez & Fyffe, 2007) these INs were identified as
IaINs (Alvarez et al. 2005; Siembab et al., 2010). In neonatal mice, RCs can be uniquely
identified by high expression levels of the calcium binding protein, calbindin (CB)
(Geiman et al., 2000). Synaptic terminals of RCs on MNs and spinal interneurons are first
observed at E15.5 and are abundant by E17.5 (Siembab-Neff, 2009).
Figure 9 shows a low magnification (20X) image of the ventral horn of the spinal
cord taken using a confocal microscope. Retrograde tracing of dorsal root L4 afferents
produced dense primary afferent labeling in the ventral horn of the postnatal P0/P1 spinal
cord. As shown earlier in this study, there was a clear band of eGFP labeled cells in
lamina VII surrounding IX (Figure 9). The primary afferent labeling clearly showed
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axons approaching and making contacts with different neurons in the ventral horn of the
spinal cord including MNs (Figure 9). CB-IR was also very strong in some interneurons.
Viewed at higher magnification (60X), eGFP expressing cells in the ventral horn
of the spinal cord could be divided into several categories. Some eGFP positive neurons
received clear contacts from RHOD-IR primary afferents, but did not receive contacts
from CB positive terminals (Figure 10D). Others received CB-IR contacts, but not
primary afferent contacts (Figure 11D). Some received both types of contacts (Figure
12D), and still others received no discernible contacts from primary afferents or CB-IR
fibers (Figure 13).
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Figure 9: Illustration of retrograde labeling of primary afferents at low
magnification in a GlyT2-eGFP mouse spinal cord. A) Confocal image of a transverse
section of L4 showing brightly labeled eGFP cells in the ventral horn of the spinal cord.
B) Primary afferent projections approaching from dorsal into the ventral horn of the
spinal cord. C) Brightly labeled calbindin contacts (puncta) and strongly labeled
calbindin cell somata shown in a confocal image of a transverse section of L4 in the
ventral horn of the spinal cord. D) Merge view of a confocal image showing eGFP
positive cells (green), primary afferent labeling (red), and calbindin immunoreactivity
(blue) in the ventral horn of the spinal cord.
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Figure 10: Demonstration of retrograde labeling of primary afferents at higher
magnification in lamina VII of a GlyT2-eGFP mouse spinal cord. A) 60X confocal
image of brightly labeled eGFP neurons. B) Rhodamine-dextran labeled primary
afferents viewed at 60X. C) Merged view at 60X of eGFP positive cells (green) receiving
primary afferents contacts (puncta in red) surrounding the cells. D) Zoomed view of a
single eGFP positive cell. The arrows point towards the primary afferent contacts at the
cell surface.
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Figure 11: Illustration of calbindin IR at a higher magnification in the lamina VII of
a GlyT2-eGFP mouse spinal cord. A) 60X confocal image of brightly labeled eGFP
neurons. B) Image of strongly labeled calbindin contacts (puncta) and some neurons that
are strongly positive for calbindin in the cell soma viewed at 60X. C) Merged view at
60X of eGFP positive cells (green) receiving calbindin contacts (puncta in magenta)
surrounding the cells. D) Zoomed view of a single eGFP positive cell. The arrows point
towards the calbindin contacts along the cell surface.
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Figure 12: Illustration of identification of IaINs in the lamina VII of the ventral
horn of a GlyT2-eGFP mouse spinal cord. A) A single eGFP positive cell imaged at
60X. B) Image showing retrograde labeled afferents (red) making contacts with the eGFP
positive cell. The arrows point to primary afferent contacts surrounding the cell. C) The
same eGFP positive cell was observed to be receive calbindin contacts. Blue arrowheads
point to calbindin contacts (magenta puncta) found surrounding the cell. D) Merged view
representing eGFP positive cells (green) receiving primary afferent contacts (red) and
strong calbindin contacts (magenta puncta). Arrows and arrowheads as in B and C.
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Quantitative analysis of these cell populations was carried out by taking several
overlapping 60X images from a single section and reassembling the images to create a
high magnification montage of the area surrounding lamina IX using CorelDraw
software. A lower magnification image (20X) of the same area was used as a guide in
assembling the montage (Figure 13). Once the pool was mapped out in CorelDraw, each
GFP positive cell in lamina VII of the individual 60X images was analyzed for the above
mentioned criteria to identify and characterize IaINs. This was performed with the
original three dimensional image stacks using Imaris software and required analysis of
possible synaptic contacts on a given neuron in all the individual optical sections in an
image. Several sections from total of four animals at P0/P1 (n=4) were analyzed and
data for the different types of neurons identified is presented in Table 3. After averaging
the data from different sections of the same animal, total average values (±SEM) for
P0/P1 (n=4) were calculated (Table 4) and the percent count of different neurons
including IaIN was plotted into a graph (Figure 14).
Our results show that on average, , 16 percent of eGFP expressing cells in the
lamina VII of ventral horn of the spinal cord did not receive any primary afferent contacts
or RC inputs and were characterized as GFP-only neurons. eGFP expressing cells
receiving only inputs from RHOD-IR primary afferents accounted for 22 percent of the
total population. In contrast, more than one-fourth of the total population (29%) of eGFP
positive cells received brightly labeled CB-IR RC contacts. IaINs were carefully
identified as eGFP expressing cells receiving inputs from RHOD-IR primary afferents
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Figure 13: Illustration of technique used to carry out the quantitative analysis of
IaINs found in lamina VII of a GlyT2-eGFP mouse. A) Merged 20X confocal image
showing the retrograde labeled primary afferents (red), eGFP positive cells (green), and
calbindin signals. Some cells strongly expressing calbindin can also be viewed in this
image. B) Montage of several 60X images assembled in CorelDraw using the 20X
confocal image of the same section as a guiding tool. This map was further used to locate
different subsets of cells including IaINs and measure them in a quantitative manner.
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Figure 14: Graphical representation identified subsets of eGFP neurons found in
lamina VII of GlyT2-eGFP P0/P1 mice. eGFP expressing cells in lamina VII were
divided into several groups based on contact status from primary afferents and calbindin
IR terminals. Average values for each group (±SEM) derived from P0/1 animals (n=4)
are plotted in this graph.
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and CB-IR RC inputs measured in quantitative manner and accounted for 17 percent of
the glycinergic neurons in lamina VII. Lastly, there was a subset of eGFP positive
neurons (16%) that were observed to be strongly labeled with Calbindin in their soma but
lacked primary afferent contacts (Table 4). After careful consideration, we came to a
conclusion that they do meet the criteria of being a RC hence might account for a subset
of RCs located in lamina VII of a spinal cord. Altogether, our study proved that GlyT2eGFP transgenic mice model can be successfully used to identify and quantify the IaINs
at as early as postnatal day 0.
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Conclusion:
Our analysis has shown that GlyT2-eGFP mice model is a most useful and
powerful tool for immunohistochemically labeling glycinergic neurons at early
developmental stages like embryonic day 17.5, postnatal day 0 and day1.
Based on the consistency of eGFP-Glycine overlay results between E17.5 and
P0/P1, we can suggest that the model is as accurate in identifying IaINs at E17.5 as it is
for postnatal day 0 and 1. Thus we are confident we can reliably use the GlyT2-eGFP
model in our future experiments.
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VI.

DISCUSSION

Our results suggests that BAC-GlyT2-EGFP mice model allows labeling of more
than 98% of glycinergic neurons by eGFP-Glycine overlay at late embryonic E17.5 and
postnatal P0/P1 stage. Further our results confirmed that IaINs are found in the lamina
VII, adjacent to lamina IX and suggests that IaINs accounts for 17% of the total eGFP
expressing cell population in the lamina VII of ventral horn of postnatal mice spinal cord.
Previous studies have utilized the BAC-GlyT2-eGFP transgenic mouse model for
studying glycinergic neurons. One study concluded that the “vast majority of either
glycine or eGFP positive neurons were doubly labeled” for GFP and glycine (Zeilhofer et
al., 2005). A second study used the model as a part of their study to show that putative
glycinergic, GABAergic, and glutamatergic commissural interneurons are expressed in
almost equal numbers in mice spinal cord (Restrepo et al., 2009). Restrepo and
colleagues did not justify exactly how efficient in quantitative manner the BAC-eGFPGlyT2 model was in identifying glycinergic neurons at P0/P1. Quantitative answers to
several questions were not provided in these studies. Were there any false positive or
false negative labeled cells? False positives are defined as cells which were eGFP
positive but not glycine positive. In contrast, false negatives are defined as cells which
were seen to be glycine positive but not eGFP positive. Thus it was important to carry out
this study to determine quantitatively how faithful the GFP expression replicated the
distribution of glycinergic neurons in the spinal cord. We found that exactly 1.8 % and
1.1% of glycine positive cells did not express eGFP in E17.5 and P0/P1 stages
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respectively. These cells can be counted as false negatives. The eGFP may well be
expressed by those cells, but because the eGFP intensities in those cells were below the
background cut off points they were counted as negative for eGFP. Whereas, we found
9.2% at E17.5 and 9.7% at P0/P1 of eGFP positive cells which did not express glycine,
again those can be counted as false positives. The glycine may well be expressed by
those 9.2% cells at E17.5 or 9.7 % cells at P0/P1, but because the glycine intensities were
below the background cut off points they were counted as negative for glycine. This
suggests that the BAC-eGFP-GlyT2 mice model either lacked to express eGFP in 1-2%
of the glycinergic neurons found in the lamina VII at E17.5 and P0/P1 or those cells
were “false negative cells” which were observed to strongly labeled for glycine but
weakly (below background cut off point).labeled for eGFP.
The past studies which Zeilhofer and Restropo conducted using BAC-GlyT2eGFP mice model lacked to show the identification of glycinergic neurons at an
embryonic stage E17.5. The eGFP expression is known to be already very high in GlyT2eGFP mice embryos at E13 or E14, the rationale for using E17.5, P0 and P1 for our
studies was based on the Ia afferent to motoneuron connectivity study carried out by
Mears and Frank in 1997. Frank observed that axons of Ia afferents were found to be
overlapping with the dendrites of motorneurons as early as E15.5, but did not record any
sensory motor connections until E17.5 (Mears and Frank 1997). Even at this early stage
the Ia afferent connectivity with homonymous motorneurons in mice was shown to be
highly specific and remained that way throughout the first postnatal week (Mears &
Frank, 1997). But no knowledge of the onset of Ia afferent connectivity to IaINs is gained
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in last several years as till date. Several studies using BAC-GlyT2-eGFP mice models
have shown to be successfully labeling glycinergic neurons including IaINs in mice
(Zeilhofer et al., 2005; Alvarez et al., 2005; Restrepo 2009), but no one has tested the
eGFP expression at embryonic stage, hence there was a need for testing and validating
the model at embryonic stage before it could be further used for studying early
developmental stages of RI circuit.
Our results show that at E17.5, the labeling of glycinergic neurons using BACeGFP-GlyT2 is consistent with that shown at P0/P1 (<98%). However, the BAC-eGFPGlyT2 model lacked labeling1-2% of glycinergic cells in our study. Again those 1-2%
cells can be counted as false positives i.e. the glycine may well be expressed by those 12% eGFP cells but the intensity of the glycine channel in those particular cells were
below the background cutoff point and hence those cells were counted as negative for
glycine. . Altogether from our study we can say that the BAC-eGFP-GlyT2 transgenic
mouse model is efficient in labeling more than 98% (98.2% at E17.5 & 98.8% at P0/P1)
of glycinergic neurons in the spinal cord at as early as embryonic day 17.5.
Past studies have proved that different markers including neuropeptides or
calcium-binding proteins like Calbindin expressed in neurons such as GABAergic
neurons helps in defining its anatomical organization (Demeulemeester et al., 1991). The
generation of BAC-eGFP-GlyT2 transgenic mice, which drives the eGFP expression
under the control on GlyT2 promoter, represents additional powerful tool for studying
functional role of glycinergic projections in the CNS (Zeilhofer et al., 2005). Although
GlyT2 is proved to be a valuable tool for labeling glycinergic neurons in past (Poyatos et
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al., 1997; Spike et al., 1997) it immunoreactivity is restricted to only axon terminals,
using eGFP-GlyT2 transgenic mice model combined with immunohistochemical
immunostaining with Glycine and GlyT2 considerably extends past observations notably
by labeling the glycinergic neurons including their soma, dendrites and axon terminals
(Zeilhofer et al, 2005).
One of the limitations for using this technique is relying on a protein expression
driven under the promoter GlyT2 gene to label the glycinergic neurons. Glycine antibody
labels the cell body and dendrites but sometimes there can be variability in the labeling of
the neurons depending on the expression of the protein present in one neuron to other. In
contrast GlyT2 is a unique gene marker for labeling glycinergic neurons. Ideally
immunohistochemical labeling using glycine in combination with GlyT2 would be
optimal. An alternative technique that could have been used to confirm the glycinergic
nature of GFP+ cells, would have combined with in situ hybridization of mRNA
encoding glycine transporter 2 (GlyT2) with GFP expression in tissue slices. (Restrepo et
al, 2009). In situ hybridization technique is a powerful method to identify glycinergic
neurons as it only labels cell bodies of the neurons that almost certainly use glycine as
their neurotransmitter. Due to the limited resources available for our present study the
demonstration of this technique was not possible in given time, but it is something our lab
is considering for future studies.
Having demonstrated the usefulness of the GlyT2-GFP model, the second focus
of this thesis was to map, locate and identify in a quantitative manner the IaINs located in
the lamina VII early postnatal stages using BAC-GlyT2-eGFP mice.
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Mears and Frank in 1997 using electrophysiology demonstrated that Ia afferent
connectivity with motoneurons were observed to be highly specific from embryonic
stages (E17.5) till the first postnatal week (Mears & Frank, 1997). More than a decade
later using electrophysiology Wang and his team showed that RI circuit is functional
even at P0 in mice (Wang et al. 2008). Above mentioned studies suggest that the Ia
afferent connectivity to motoneurons is highly specific even at embryonic stage but no
one looked into how specific the Ia afferent connectivity with IaINs is? What anatomical
or functional change takes place if any during the embryonic development of RI
pathway? From our study we have validated that GlyT2-eGFP mice model is an accurate
model to study the IaIN location, function and Ia afferent to IaIN connectivity in a late
embryonic developmental stage till postnatal day P1.
In mature spinal cords, IaINs were previously identified histologically by
Parvalbumin (PV)/ RC expression and proprioceptive inputs, labeled respectively by CB
and VGLUT1 (Alvarez et al., 2005). Parvalbumin is calcium binding albumin protein
which is found to be expressed in abundance in GABAergic neurons. Identification of
RCs can be carried out using calcium binding protein, Calbindin (Geiman et al., 2000).
Previous studies have shown that RC and Ia afferent inputs are a unique criteria for
identification of interneurons mediating reciprocal inhibition in lumbar spinal cord
(Hultborn et al., 1971; Jankowska and Lindstrom, 1972; Alvarez et al., 1997). Ia afferents
enter the spinal cord dorsally and make contacts with the IaINs and motorneurons to
mediate the process of RI in the ventral horn of the spinal cord (Eccles et al. 1956). This
anatomical arrangement gives an opportunity to investigate the location of the Ia
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interneurons in relation to the primary afferents which excites them and to other
interneurons or motorneurons which they are supposed to inhibit.
In the present study anatomical tracing was carried out on L4 spinal segment by
filling dorsal root 4 with RHOD dextran to search for Ia inhibitory interneurons.
Characteristics of interneurons in the Ia inhibitory pathway were used as a key marker to
identify them in the lamina VII of ventral horn of postnatal GlyT2-eGFP mice. Although
studies in past have focused on the identification of IaINs, no one has looked into
carefully identifying number of IaINs compare to other neurons in a quantitative way at
neonatal stage. This quantification will allow researchers to have an idea of exactly how
carefully one needs to look into the lamina VII to identify IaINs via electrophysiological
assays. By knowing that out of the total cell population in the lamina VII of the spinal
cord at postnatal stages P0 or P1, IaINs accounts for only 17% percent, sheds some light
on probability of locating an IaIN in the lamina VII, while doing electrophysiological
experiments for measuring their functionality in the RI circuit.
This study is the first to carry out identification of IaINs using GlyT2-eGFP mice
model. One advantage using this technique is that we were able to identify the IaINs at
postnatal day P0 and P1. The studies in past used PV as a marker to label IaINs in
combination with Calbindin and primary afferent inputs in adult mice, and demonstrated
that in adults IaINs accounts for 13% of the total V1 derived interneurons in the spinal
cord (Alvarez et al, 2005). Our analysis at early postnatal stages shows that
approximately 17% of total eGFP expressing cell population found in the lamina VII,
dorsal and medial to lamina IX, were found to be IaINs. Therefore one could assume that
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the number to IaINs do not change much as the animal develops but instead may be the
Ia afferent connections with IaINs strengthens in the circuit making the circuit more
specific as the animal develops. One step ahead from here would be identifying a
specific protein, enzyme or neuropeptide which is restricted to only IaINs, and would
efficiently label all the IaINs found in the ventral horn of the spinal cord.
Together with the identification of IaINs, the GlyT2-eGFP also demonstrated
subset of neurons which received bright Calbindin contacts but no primary afferent inputs
or strong primary afferents but no Calbindin contacts, those neurons may account for
other important and interesting neurons but for now we are not aware of their functions in
the lamina VII of postnatal mice spinal cord.

Future studies:
For RI circuit to be functionally normal, appropriate Ia afferent connections must
be made with specific IaINs and those IaINs must make further contacts with their
targeted MNs. Quadriceps (Quad) and Adductors (Add) afferents make connections with
specific IaINs in the RI pathway. For example stimulation of Quad muscle group (knee
extensors) results in disynaptic inhibition of MNs projecting to posterior biceps /
semitendinosus muscles (PBST, knee flexors) (Eccles and Lundberg, 1958). But
stimulation of Add muscle group does not inhibit the PBST MNs, even though they both
enter the spinal cord via the same dorsal root and terminate in the same area where IaINs
are located. This suggests that the subsets of IaINs that project to and inhibit PBST MNs
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are contacted by Quad afferents only, and not Add afferents. The RI circuit is known to
be functional at P0 (Wang et al., 2008).
For future studies we want to determine the anatomical organization and
functionality of RI circuit in the late embryonic stages to see how early in the
development of RI circuit are those connections first made and how appropriate are those
connections. We would like to test the hypothesis that more inappropriate Ia afferent
connections exists prenatally than postnatally in the RI circuit. The study would be
carried out using GlyT2-eGFP mice at embryonic stage E17.5, E18.5 and postnatal stages
P0 and P1.We would look at the status of afferent connections with IaINs in embryos up
till postnatal day P1, by labeling the afferents projections to specific muscles with
strategies similar to what used in present study.
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